Want FREE Templates on Organization, Change, & Culture? Download our FREE compilation of 50+ slides. This is an exclusive promotion being run on LinkedIn.







Flevy Management Insights Case Study
Strategic Growth Plan for Bioplastics Manufacturer in Global Markets


There are countless scenarios that require Innovation Management. Fortune 500 companies typically bring on global consulting firms, like McKinsey, BCG, Bain, Deloitte, and Accenture, or boutique consulting firms specializing in Innovation Management to thoroughly analyze their unique business challenges and competitive situations. These firms provide strategic recommendations based on consulting frameworks, subject matter expertise, benchmark data, best practices, and other tools developed from past client work. Let us analyze the following scenario.

Reading time: 10 minutes

Consider this scenario: A mid-size bioplastics manufacturer in North America is at a critical juncture, needing a refined approach to innovation management to stay competitive.

Facing a 20% decline in market share due to increased global competition and a surge in raw material costs, the company is also contending with internal challenges such as outdated production technology and processes. The primary strategic objective is to achieve a 25% growth in market share and improve profitability through innovation in product development and operational efficiency over the next 5 years.



This organization, a pioneer in the bioplastics sector, is encountering stagnation as a result of its slow response to market demands and a lack of process innovation. The outdated technology and resistance to adopting new, more efficient production methods are the core issues that prevent it from capitalizing on the growing demand for sustainable materials. Addressing these concerns is crucial for regaining its competitive edge and ensuring long-term sustainability.

Market Analysis

The bioplastics industry is witnessing rapid growth due to increasing environmental concerns and the push for sustainable alternatives to conventional plastics. However, this growth is accompanied by intensified competition and changing regulatory standards worldwide.

We analyze the competitive landscape without explicitly mentioning Porter's Five Forces, but by considering the dynamics that shape industry competition.

  • Internal Rivalry: Intense, as more companies enter the space, including startups innovating with new materials and established plastics manufacturers pivoting to bioplastics.
  • Supplier Power: Moderate, with suppliers of bio-based raw materials gaining leverage due to the growing demand but still facing competition.
  • Buyer Power: High, as consumers and corporations demand more sustainable options but are also price-sensitive.
  • Threat of New Entrants: High, given the relatively low initial capital required for small-scale, innovative startups.
  • Threat of Substitutes: Moderate to high, with ongoing research into alternative sustainable materials posing a potential threat.

Emerging trends in the industry include a shift towards fully biodegradable products and the development of bioplastics with enhanced performance characteristics. Major changes in the industry dynamics include:

  • Increased regulatory pressure for sustainability, creating both the challenge of compliance and the opportunity for market differentiation.
  • Consumer demand for environmentally friendly products, offering a chance to capture a niche market but requiring significant investment in marketing and education.
  • Technological advancements in bioplastic materials, presenting the opportunity for product innovation but necessitating continuous R&D investment.

The STEEPLE analysis reveals that technological and environmental factors are the most significant external forces impacting the industry, with regulations and consumer awareness driving demand for sustainable materials.

Learn more about Porter's Five Forces STEEPLE Competitive Landscape Market Analysis

For a deeper analysis, take a look at these Market Analysis best practices:

Market Analysis and Competitive Positioning Assessment (45-slide PowerPoint deck)
Customer Development Model (CDM) (28-slide PowerPoint deck)
Introduction to Market Analysis (36-slide PowerPoint deck)
Building a Market Model and Market Sizing (22-slide PowerPoint deck)
Market Research Method (109-slide PowerPoint deck)
View additional Innovation Management best practices

Are you familiar with Flevy? We are you shortcut to immediate value.
Flevy provides business best practices—the same as those produced by top-tier consulting firms and used by Fortune 100 companies. Our best practice business frameworks, financial models, and templates are of the same caliber as those produced by top-tier management consulting firms, like McKinsey, BCG, Bain, Deloitte, and Accenture. Most were developed by seasoned executives and consultants with 20+ years of experience.

Trusted by over 10,000+ Client Organizations
Since 2012, we have provided best practices to over 10,000 businesses and organizations of all sizes, from startups and small businesses to the Fortune 100, in over 130 countries.
AT&T GE Cisco Intel IBM Coke Dell Toyota HP Nike Samsung Microsoft Astrazeneca JP Morgan KPMG Walgreens Walmart 3M Kaiser Oracle SAP Google E&Y Volvo Bosch Merck Fedex Shell Amgen Eli Lilly Roche AIG Abbott Amazon PwC T-Mobile Broadcom Bayer Pearson Titleist ConEd Pfizer NTT Data Schwab

Internal Assessment

The organization has a strong foundation in the bioplastics market, with a reputation for quality products and a dedicated customer base. However, it struggles with operational inefficiencies and slow adoption of new technologies.

The MOST analysis suggests that the company’s Mission to lead in sustainable materials is challenged by outdated Strategies that focus on traditional manufacturing processes. Its Objectives of market share growth and profitability improvement require a realignment of Tactics to embrace innovation and operational excellence.

In the Value Chain Analysis, inefficiencies in production processes and supply chain management are identified as key areas for improvement. Streamlining these areas could significantly reduce costs and improve product availability.

The Distinctive Capabilities Analysis indicates that while the company has a strong brand and customer loyalty, it needs to build capabilities in innovation and agile production methods to respond to market changes more effectively.

Learn more about Operational Excellence Supply Chain Management Agile

Strategic Initiatives

  • Innovation in Bioplastic Materials: Develop new, high-performance bioplastics through dedicated R&D efforts, aiming to meet the growing market demand for sustainable materials. This initiative is expected to create value by differentiating the company’s product offerings and capturing a larger market share. It will require investment in new technologies and R&D capabilities.
  • Operational Efficiency Improvement: Implement lean manufacturing principles and invest in state-of-the-art production technology to reduce waste and production costs. The initiative aims to improve margin and competitiveness by lowering the cost base. This will involve capital investment in new equipment and training for staff.
  • Market Expansion Strategy: Enter new international markets with high demand for bioplastics, leveraging the company's sustainable product offering. This initiative is expected to increase revenue and diversify market risk. It requires market analysis, regulatory compliance efforts, and the establishment of distribution partnerships.

Learn more about Lean Manufacturing Market Analysis

Innovation Management Implementation KPIs

KPIS are crucial throughout the implementation process. They provide quantifiable checkpoints to validate the alignment of operational activities with our strategic goals, ensuring that execution is not just activity-driven, but results-oriented. Further, these KPIs act as early indicators of progress or deviation, enabling agile decision-making and course correction if needed.


If you cannot measure it, you cannot improve it.
     – Lord Kelvin

  • Product Development Cycle Time: This KPI will track the efficiency of the R&D process in bringing new products to market, indicating the effectiveness of innovation management.
  • Production Cost Reduction: A measure of operational efficiency improvements, reflecting success in lean manufacturing implementation.
  • Market Share Growth: An indicator of the company’s success in expanding into new markets and increasing its footprint in the bioplastics industry.

Monitoring these KPIs provides insights into the effectiveness of the strategic initiatives, allowing for timely adjustments to strategy and execution to ensure alignment with the overall strategic objectives of growth and profitability improvement.

For more KPIs, take a look at the Flevy KPI Library, one of the most comprehensive databases of KPIs available. Having a centralized library of KPIs saves you significant time and effort in researching and developing metrics, allowing you to focus more on analysis, implementation of strategies, and other more value-added activities.

Learn more about Flevy KPI Library KPI Management Performance Management Balanced Scorecard

Innovation Management Best Practices

To improve the effectiveness of implementation, we can leverage best practice documents in Innovation Management. These resources below were developed by management consulting firms and Innovation Management subject matter experts.

Innovation Management Deliverables

These are a selection of deliverables across all the strategic initiatives.

  • Innovation Management Framework (PPT)
  • Operational Efficiency Roadmap (PPT)
  • New Market Entry Plan (PPT)
  • Financial Impact Model (Excel)
  • Product Development Pipeline Template (Excel)

Explore more Innovation Management deliverables

Innovation in Bioplastic Materials

The strategic team applied the Resource-Based View (RBV) framework to guide the Innovation in Bioplastic Materials initiative. RBV is a management tool used to identify and leverage a firm's internal resources that can provide competitive advantage. It was particularly relevant for this initiative as it helped the organization focus on its unique capabilities in research and development, which are critical for innovation in the bioplastics sector. The team executed the framework as follows:

  • Conducted an internal audit to identify resources and capabilities that could be leveraged for developing new bioplastic materials.
  • Evaluated the organization's R&D capabilities against market needs to identify gaps and areas for improvement.
  • Allocated resources towards enhancing the R&D department, including hiring additional scientists and investing in new technologies.

Additionally, the Scenario Planning framework was utilized to anticipate future trends in the bioplastics industry and align the product development pipeline accordingly. Scenario Planning allowed the organization to explore various future market scenarios and how emerging technologies could impact product innovation. The process involved:

  • Developing multiple scenarios based on potential regulatory changes, technological advancements, and shifts in consumer preferences.
  • Assessing the impact of each scenario on the demand for bioplastic materials and identifying the technologies needed to meet these demands.
  • Adjusting the innovation strategy to prioritize R&D projects that aligned with the most likely scenarios.

The combination of the Resource-Based View and Scenario Planning frameworks enabled the company to effectively direct its innovation efforts. As a result, the organization successfully developed several new bioplastic materials that met emerging market needs and regulatory requirements. These innovations positioned the company as a leader in sustainable materials, leading to increased market share and enhanced competitive advantage.

Learn more about Competitive Advantage Scenario Planning

Operational Efficiency Improvement

For the Operational Efficiency Improvement initiative, the organization implemented the Lean Six Sigma framework. Lean Six Sigma is a methodology that combines the waste-reduction principles of Lean manufacturing with the process improvement strategies of Six Sigma. It was chosen for its effectiveness in identifying inefficiencies and reducing variability in manufacturing processes. The implementation steps included:

  • Mapping out all manufacturing processes to identify waste and areas of variability that could be eliminated.
  • Training key personnel in Lean Six Sigma principles and techniques.
  • Forming cross-functional teams to carry out process improvement projects.

This initiative also made use of the Theory of Constraints (TOC) to systematically improve the company's operational performance. TOC is a management paradigm that focuses on identifying and managing the bottleneck or constraint that limits the throughput of any system. The application of TOC involved:

  • Identifying the major constraints within the production cycle that were causing delays and inefficiencies.
  • Reorganizing production schedules and workflows to address these constraints.
  • Implementing continuous monitoring and improvement processes to ensure that constraints were effectively managed over time.

The implementation of Lean Six Sigma and the Theory of Constraints significantly enhanced the company's manufacturing efficiency. Waste was drastically reduced, and production throughput increased, leading to lower production costs and improved product availability. These improvements not only enhanced the company’s profitability but also its ability to compete on price and delivery in the highly competitive bioplastics market.

Learn more about Process Improvement Six Sigma Theory of Constraints

Market Expansion Strategy

To support the Market Expansion Strategy, the organization utilized the PESTEL Analysis framework to understand the macro-environmental factors that could impact its entry into new markets. PESTEL Analysis examines the Political, Economic, Social, Technological, Environmental, and Legal factors that could influence business operations. This framework was instrumental in identifying the most favorable markets for expansion. The team executed the framework by:

  • Conducting comprehensive PESTEL analyses for several target countries to evaluate the business environment.
  • Identifying markets with favorable environmental regulations and high consumer demand for sustainable products.
  • Assessing the potential impact of economic and political stability on business operations in these markets.

Furthermore, the organization adopted the Market Segmentation, Targeting, and Positioning (STP) framework to refine its market entry strategy. STP enabled the company to identify specific customer segments within these new markets that were most likely to adopt bioplastic products. The process involved:

  • Segmenting the market based on demographic, psychographic, and behavioral factors.
  • Targeting segments with the highest propensity to purchase bioplastic products.
  • Positioning the company’s products to meet the unique needs and preferences of these segments.

The strategic application of PESTEL Analysis and the STP framework facilitated a successful market expansion. The company was able to identify and enter new markets with high growth potential for bioplastic products. This strategic move not only diversified the company's revenue streams but also established its presence as a global leader in sustainable materials, contributing significantly to its overall growth objectives.

Learn more about Market Segmentation Market Entry PEST

Additional Resources Relevant to Innovation Management

Here are additional best practices relevant to Innovation Management from the Flevy Marketplace.

Did you know?
The average daily rate of a McKinsey consultant is $6,625 (not including expenses). The average price of a Flevy document is $65.

Key Findings and Results

Here is a summary of the key results of this case study:

  • Developed several new bioplastic materials, positioning the company as a leader in sustainable materials and increasing market share.
  • Implemented Lean Six Sigma and the Theory of Constraints, reducing production costs and improving product availability.
  • Entered new international markets with high demand for bioplastics, diversifying revenue streams and establishing a global presence.
  • Reduced product development cycle time through effective innovation management, enhancing the company's ability to meet market demands promptly.
  • Increased operational efficiency, leading to a significant reduction in waste and production costs.
  • Successfully leveraged the company's unique R&D capabilities to meet emerging market needs and regulatory requirements.

The strategic initiatives undertaken by the bioplastics manufacturer have yielded significant positive outcomes, notably in market share growth, operational efficiency, and innovation in product development. The implementation of Lean Six Sigma and the Theory of Constraints has notably reduced production costs and improved product availability, directly addressing the company's initial challenges of operational inefficiency and outdated production technology. The development of new bioplastic materials and the successful entry into new markets have not only diversified the company's revenue streams but also solidified its position as a leader in sustainable materials. However, the results were not without their shortcomings. The high initial investment in R&D and new technology adoption posed financial risks, and the full impact on profitability over the short term was not as pronounced as expected. Additionally, the rapid expansion into new markets brought about challenges in supply chain management and regulatory compliance, which were not fully anticipated.

Given the mixed results, it is recommended that the company continues to focus on innovation in bioplastic materials while also seeking ways to optimize its R&D spending. Exploring strategic partnerships or collaborations could enhance the company's innovation capabilities without necessitating significant capital investment. Furthermore, a more cautious and calculated approach to market expansion, possibly through joint ventures or partnerships, could mitigate risks associated with regulatory compliance and supply chain complexities. Lastly, continuous improvement in operational efficiency should remain a priority, with an emphasis on further integrating Lean Six Sigma principles across all aspects of the business to enhance profitability and competitiveness.

Source: Strategic Growth Plan for Bioplastics Manufacturer in Global Markets, Flevy Management Insights, 2024

Flevy is the world's largest knowledge base of best practices.


Leverage the Experience of Experts.

Find documents of the same caliber as those used by top-tier consulting firms, like McKinsey, BCG, Bain, Deloitte, Accenture.

Download Immediately and Use.

Our PowerPoint presentations, Excel workbooks, and Word documents are completely customizable, including rebrandable.

Save Time, Effort, and Money.

Save yourself and your employees countless hours. Use that time to work on more value-added and fulfilling activities.




Read Customer Testimonials




Additional Flevy Management Insights

Download our FREE Strategy & Transformation Framework Templates

Download our free compilation of 50+ Strategy & Transformation slides and templates. Frameworks include McKinsey 7-S Strategy Model, Balanced Scorecard, Disruptive Innovation, BCG Experience Curve, and many more.